
Quest Diagnostics Incorporated: updates and filings
Price
$258.86
November 19, 2026Market cap $28.4B
What Ploutos Investor adds for Quest Diagnostics
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Oct 22, 2026next Jan 21, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
October 2026
July 2026
May 2026
April 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 10, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Oct 23, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Oct 22, 2026Other material eventsForm8-K
- Oct 22, 2026Results of operationsForm8-K
- Oct 6, 2026Officer or director changeForm8-K
- Aug 14, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jul 23, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Jul 23, 2026Results of operationsForm8-K
- Jun 18, 2026Employee stock plan reportfor the period to Dec 31, 2025Form11-K
- May 21, 2026Shareholder voteForm8-K
- May 8, 2026Material agreement enteredForm8-K
- May 1, 2026Other material eventsForm8-K
- Apr 30, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Apr 29, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Apr 22, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- Apr 21, 2026Results of operationsForm8-K
- Apr 6, 2026Additional annual meeting materialFormDEFA14A
- Apr 6, 2026Annual meeting proxy statementFormDEF 14A
- Mar 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Mar 12, 2026Officer or director change, Regulation FD disclosureForm8-K
- Feb 26, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Feb 10, 2026Results of operations, other material eventsForm8-K
- Jan 12, 2026Results of operations, Regulation FD disclosureForm8-K
- Oct 21, 2025Results of operationsForm8-K
- Oct 21, 2025Quarterly reportfor the period to Sep 30, 2025Form10-Q
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 10, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Oct 23, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Oct 22, 2026 | 8-K | Other material events | Document |
| Oct 22, 2026 | 8-K | Results of operations | Document |
| Oct 6, 2026 | 8-K | Officer or director change | Document |
| Aug 14, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jul 23, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Jul 23, 2026 | 8-K | Results of operations | Document |
| Jun 18, 2026 | 11-K | Employee stock plan reportfor the period to Dec 31, 2025 | Document |
| May 21, 2026 | 8-K | Shareholder vote | Document |
| May 8, 2026 | 8-K | Material agreement entered | Document |
| May 1, 2026 | 8-K | Other material events | Document |
| Apr 30, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Apr 29, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Apr 22, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| Apr 21, 2026 | 8-K | Results of operations | Document |
| Apr 6, 2026 | DEFA14A | Additional annual meeting material | Document |
| Apr 6, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Mar 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Mar 12, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Feb 26, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Feb 10, 2026 | 8-K | Results of operations, other material events | Document |
| Jan 12, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Oct 21, 2025 | 8-K | Results of operations | Document |
| Oct 21, 2025 | 10-Q | Quarterly reportfor the period to Sep 30, 2025 | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Sep 23, 1996. Of its note and share prospectuses (424B, FWP), the newest 40 of 46.
The full analysis
What do Quest Diagnostics's filings show?
The filings are where every one of Quest Diagnostics's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.